|
|
Welcome to the COVID-19 Vaccine Partner Newsletter! Here you'll find the latest news and information on COVID-19 vaccine related topics.
|
|
 NEW RESOURCE - THE PREGNANCY AND COVID-19 VACCINES TOOLKIT
The Pregnancy and COVID-19 Vaccines Toolkit is now available. This toolkit provides information and resources for medical providers and community partners to educate and inform patients and clients on the importance of getting vaccinated and staying up to date with their COVID-19 vaccination before, during, and after pregnancy. This toolkit is a collection of local and national resources, and provides answers to Frequently Asked Questions, handouts and flyers, sample social media posts, co-brandable materials, and more! This resource will be available soon in Spanish. Check out the Pregnancy Toolkit today!
|
|
COVID-19 VACCINE FOWARD CAPACITY SURVEY
The Washington State Department of Health has committed in the state’s ForWArd Plan to supporting vaccination efforts throughout the state. We are committed to maintaining the system-wide capacity to administer 30,000 doses of COVID-19 vaccine per day and the ability to surge to 60,000 doses daily within seven days as needed. A survey will be used to measure the maximum capacity, on a monthly basis, that enrolled COVID-19 Vaccine Providers have to administer COVID-19 vaccines to patients.
Thank you for your participation in the September COVID-19 Provider Capacity survey. Your answers in the last survey showed that we are ready to meet this goal in the ForWArd Plan! Please take a few moments to answer the questions in the next survey to help us measure provider capacity to meet these state goals. The survey will be sent on October 1st and will be closing on October 10th.
Please contact us at COVID.Vaccine@doh.wa.gov if you have any questions about this survey.
|
|
ENCOURAGING COVID-19 VACCINATION WHEN ADMINISTERING FLU SHOT
It’s fall and the influenza vaccination efforts are in full swing. This year, the new COVID-19 bivalent booster is also now available. In order to increase uptake rates for both vaccines, convenience is key and the CDC encourages providers to offer influenza and COVID-19 vaccines at the same visit, if eligible. They stated “with both influenza and SARS-CoV-2 circulating, getting both vaccines is important for prevention of severe disease, hospitalization and death.”
Please keep this in mind when scheduling appointments and seeing your patients!
More information on the guidance can be found at Clinical Guidance for COVID-19 Vaccination | CDC.
|
|
COME SEE US NEXT WEEK ON COLLEGE CAMPUSES!
The Power of Providers (POP) continues to partner with Care-a-Van to bring mobile vaccine clinics to college campuses across the state. POP members are also getting involved, volunteering to educate students and answer questions about the updated COVID-19 booster. Turnout has been great and we look forward to vaccinating more young adults over the next month.
Next week we will be hosting four events. If you are in the area, stop by and say hello!
- October 3, 10 a.m.- 2 p.m.: University of Washington, Seattle Campus
- October 4, 10 a.m.- 2 p.m.: University of Washington, Tacoma Campus
- October 5, 10 a.m.- 2 p.m.: University of Washington, Bothell Campus
- October 6, 2 p.m.- 6 p.m.: Washington State University, Vancouver Campus
Dubs, the University of Washington mascot, is on campus during the September 21 vaccination clinic
|
|
UKRANIAN/RUSSIAN VACCINATION RECORDS
With help from DOH, Spokane County Regional Health Department has developed a vaccination record translation guide to help health workers interpret vaccination records written in Ukrainian or Russian into English. The document provides an overview of the vaccines required to attend schools in Washington state and the vaccines that children typically receive in Ukraine, along with examples of what vaccine records may look like when written in Ukrainian and Russian.
You can access this helpful guide here.
|
|
PRE-ORDERING FOR PFIZER-BIONTECH BIVALENT BOOSTER NOW OPEN
New recommendations for baby pediatric bivalent booster vaccine is expected around mid-October. COVID-19 Vaccine Program providers should not start administering these vaccines until final approval has been received from the FDA, CDC, and WSSSRW and standing orders have been updated and signed.
Pfizer-BioNTech Bivalent Booster (5 yrs-11yrs)
Pre-ordering for the Pfizer-BioNTech bivalent booster (5-11 years) is now open to all COVID-19 providers in the Immunization Information System (IIS) and will close on Monday, October 3rd at 12:00PM. After October 3rd, ordering for this product will be paused in the IIS until FDA authorization is given and ACIP recommendations are received, at which time ordering will reopen.
Moderna Bivalent Booster (6 yrs-11 yrs/12 yrs-17 yrs)
Pre-ordering will not occur for the Moderna bivalent booster (6-11 years/12-17 years) This vaccine is already in the field and is the same vial (dark blue cap, gray border) currently authorized for use in adults. This presentation is expected to be used for all age groups (people aged 6 years and older), but volume and dosage are expected to differ by age. Although this product is already in the field, administration of the Moderna bivalent booster for patients 6 years to 17 years of age has NOT been authorized yet. EUA approval is anticipated by mid-October. Ordering for this product will be listed in both the pediatric and adult COVID-19 vaccine order sets in the Immunization Information System (IIS) The difference between order sets is the number of ancillary kits a provider can receive with their order.
The Vaccine Ordering and Distribution Team will consult LHJ’s if vaccine demand is greater than supply for both products, to determine which orders will be approved, decreased and/or denied. If your order is rejected within the IIS, please review the Vaccine Advertisement Page in the WA IIS for available doses.
Due to limited availability of Moderna bivalent booster and the expanded age range it will be covering, we encourage providers to consider ordering the Pfizer-BioNTech bivalent booster in place of Moderna when patient demand allows.
|
|
MODERNA PRODUCT DESCRIPTION UPDATED IN IIS
Several changes have been made to the product description for the Moderna bivalent booster vaccine within the IIS in preparation for the expanded age range for bivalent boosters (6-17 years of age). Providers will now see that Moderna is listed as 12+ when placing an order. Providers can continue to use the option to order the Moderna bivalent vaccine, but are not able to administer it to people under the age of 18 until final approval has been received from the FDC, CDC, and WSSSRW and they have signed standing orders.
Also, when providers enter an administered vaccine on the vaccinations View/Add screen, they will notice that the Moderna bivalent booster product description is listed as Mod 6+. This option can be used to document vaccine administration to people 18 years and older at this time.
|
|
CDC UPDATED DOCUMENTS, BIVALENT BOOSTER INFORMATION
CDC updated the following documents to include bivalent booster information:
Moderna:
Pfizer:
|
|
FLU UPDATES WEBINAR FROM DOH
October 5, 2022 at 12:00pm PT
The Washington State Department of Health (DOH) is hosting a Flu Updates Webinar on Wednesday, October 5, 2022 at 12:00pm. The webinar will cover epidemiological updates on influenza (flu), provide information on flu vaccine inventory and ordering, discuss flu vaccine recommendations for different populations, and highlight communication and health promotion efforts. Continuing education credit will be available for nurses who attend the webinar.
Click here to register.
|
|
PANDEMIC TO ENDEMIC: LONG-TERM RECOVERY FOR HEALTH CARE WORKERS
October 21, 2022 12:00PM - 1:00PM MST
The Power of Providers (POP) team at DOH is excited to host this important presentation on how the COVID-19 pandemic has affected the personal and professional lives of health care workers.
Dr. Kira Mauseth, Ph.D., is a practicing clinical psychologist who will be discussing various topics such as:
- Behavioral health considerations for the current phase of the disaster and response.
- The physical and neuro-chemical processes at work that influence our risk-taking behavior, thinking and decision making in a disaster cascade and at this point in our recovery.
- Risk and harm reduction techniques as we have fun, re-engage, and recover.
- Strategies for working through grief, loss and anger, and managing our complex emotional, cognitive and interpersonal challenges.
- Finding ways to re-connect meaningfully with our work and things that matter at home and in community.
We hope you make time to join the presentation! Mark your calendar and reserve your spot today. Also, keep and eye out for more presentations from Dr. Mauseth
|
|
|
FOR SCHOOLS AND CHILD CARE FACILITIES
FOR LONG-TERM CARE FACILITIES
|
|
SIGN UP FOR THIS NEWSLETTER!
If you aren't already signed up for the COVID-19 Vaccine Partner Newsletter, please visit the Department of Health's email subscribers page here. Once you enter your email, on the next page expand the Immunization topic, select the COVID-19 Vaccine Partner Newsletter, and click submit.
|
|
This newsletter summarizes content from the week of September 25, 2022 and was sent out on September 30, 2022. |
|
|
|
|
